---
id: COMP-FDA-ML-007
framework: FDA-AIML
category: Model Transparency
title: Model Transparency and Explainability
description: Ensure AI/ML models are interpretable and transparent to support clinical decision-making and regulatory review
status: pending-verification
version: 1.0.0
last_updated: 2025-12-13
owner: compliance-team
references: []
related_cards:
  - COMP-FDA-ML-001
  - COMP-FDA-ML-002
  - COMP-EN18031-020
  - COMP-EN18031-006
tags:
  - model-transparency
  - explainability
  - medical-devices
  - ai-ml
  - fda
  - xai
priority: high
---

# COMP-FDA-ML-007: Model Transparency and Explainability

## Overview

Defines requirements for AI/ML model transparency and explainability to support clinical decision-making, regulatory review, and post-market surveillance. Model transparency is essential for clinical trust, regulatory approval, and effective clinical use.

**Regulatory Context:** FDA GMLP Principles, FDA SaMD Action Plan, 21 CFR Part 820.

---

## Model Transparency Requirements

### 1. Model Documentation

#### Acceptance Criteria
```gherkin
Feature: Model Documentation

  Scenario: Document model architecture
    Given an AI/ML model for medical device
    When documenting model architecture
    Then documentation MUST include:
      | Component                            | Requirement                 |
      |--------------------------------------|----------------------------|
      | Model type (e.g., CNN, RNN, ensemble) | Architecture description    |
      | Model structure (layers, parameters) | Architecture diagram        |
      | Input features and preprocessing     | Feature documentation       |
      | Output format and interpretation     | Output specification        |
      | Training algorithm and hyperparameters | Training configuration      |
      | Model size and computational requirements | Resource specification      |
    And documentation MUST be version-controlled
    And documentation MUST be accessible to regulatory affairs

  Scenario: Document model development process
    Given model development activities
    When documenting development process
    Then documentation MUST include:
      | Process Component                    | Documentation               |
      |--------------------------------------|----------------------------|
      | Training dataset characteristics     | Dataset documentation       |
      | Training procedure                   | Training protocol           |
      | Validation methodology               | Validation plan             |
      | Model selection criteria             | Selection rationale         |
      | Performance metrics                  | Performance report          |
      | Limitations and failure modes        | Risk analysis               |
    And development process MUST be traceable
```

**Key Controls:**
- Model architecture documentation
- Model development protocol
- Version control for model documentation
- Design history file (DHF) linking to model documentation

**Metrics:**
- Documentation completeness score
- Number of model versions documented
- Documentation review completion rate

---

### 2. Explainability and Interpretability

#### Acceptance Criteria
```gherkin
Feature: Model Explainability

  Scenario: Implement explainability methods
    Given an AI/ML model for clinical decision support
    When implementing explainability
    Then the system MUST provide:
      | Explainability Type                  | Method                      |
      |--------------------------------------|----------------------------|
      | Feature importance (global)          | SHAP, permutation importance |
      | Prediction explanation (local)       | SHAP, LIME, attention maps  |
      | Confidence/uncertainty quantification | Calibrated probabilities, prediction intervals |
      | Decision boundary visualization      | Visualization tools         |
    And explainability methods MUST be validated for accuracy
    And explanations MUST be clinically interpretable
    And explanations MUST be presented to clinicians (where appropriate)

  Scenario: Validate explanation quality
    Given explainability methods
    When validating explanations
    Then validation MUST assess:
      | Quality Aspect                       | Validation Method           |
      |--------------------------------------|----------------------------|
      | Explanation faithfulness             | Faithfulness metrics        |
      | Explanation stability                | Perturbation testing        |
      | Clinical relevance                   | Clinical expert review      |
      | Usability for clinicians             | Usability testing           |
    And validation results MUST be documented
    And explanations MUST be tested for edge cases
```

**Key Controls:**
- Explainability method implementation (SHAP, LIME, etc.)
- Explanation validation procedures
- Clinical expert review of explanations
- Usability testing with clinicians

**Metrics:**
- Explanation faithfulness score
- Explanation stability (variance under perturbation)
- Clinician satisfaction with explanations (usability score)
- Frequency of explanation usage by clinicians

---

### 3. Model Limitations and Failure Modes

#### Acceptance Criteria
```gherkin
Feature: Model Limitations Documentation

  Scenario: Document model limitations
    Given an AI/ML model
    When documenting limitations
    Then documentation MUST include:
      | Limitation Type                      | Documentation               |
      |--------------------------------------|----------------------------|
      | Population limitations (demographics, clinical characteristics) | Target population constraints |
      | Input data limitations (data quality, missing features) | Input requirements          |
      | Performance limitations (accuracy, failure rates) | Performance bounds          |
      | Use case limitations (clinical settings, contraindications) | Use case constraints        |
      | Known failure modes                  | Failure mode analysis       |
    And limitations MUST be stated in device labeling
    And limitations MUST be communicated to clinical users

  Scenario: Analyze and document failure modes
    Given model performance data
    When analyzing failure modes
    Then the analysis MUST identify:
      | Failure Mode                         | Analysis Method             |
      |--------------------------------------|----------------------------|
      | Systematic errors (bias)             | Error analysis by subgroup  |
      | Edge cases and outliers              | Outlier analysis            |
      | Input data quality issues            | Data quality failure modes  |
      | Adversarial vulnerabilities          | Adversarial testing         |
    And failure modes MUST be documented with examples
    And failure modes MUST be included in risk analysis
    And mitigation strategies MUST be defined
```

**Key Controls:**
- Model limitations documentation
- Failure mode and effects analysis (FMEA)
- Risk management file (per ISO 14971)
- Labeling review for limitations

**Metrics:**
- Number of documented failure modes
- Failure mode frequency (in real-world use)
- Mitigation effectiveness (reduction in failure rate)

---

### 4. Regulatory Submission Documentation

#### Acceptance Criteria
```gherkin
Feature: Regulatory Submission Documentation

  Scenario: Prepare model transparency documentation for regulatory submission
    Given an AI/ML device for FDA submission
    When preparing submission documentation
    Then the submission MUST include:
      | Documentation Component              | Requirement                 |
      |--------------------------------------|----------------------------|
      | Model architecture and rationale     | Technical description       |
      | Training and validation methodology  | Development protocol        |
      | Performance evaluation results       | Clinical validation report  |
      | Model limitations and failure modes  | Risk analysis               |
      | Explainability methods (if applicable) | XAI documentation           |
      | Post-market monitoring plan          | Surveillance plan           |
    And documentation MUST address FDA pre-submission feedback
    And documentation MUST be reviewed by regulatory affairs

  Scenario: Address regulatory questions on model transparency
    Given regulatory questions during review
    When responding to transparency questions
    Then responses MUST provide:
      | Question Type                        | Response Content            |
      |--------------------------------------|----------------------------|
      | Model decision-making process        | Decision logic explanation  |
      | Feature importance and rationale     | Feature analysis            |
      | Performance across subgroups         | Subgroup analysis           |
      | Model robustness                     | Robustness testing results  |
      | Model update strategy                | Change control plan         |
    And responses MUST be technically accurate
    And responses MUST be clinically relevant
```

**Key Controls:**
- Regulatory submission checklist (model transparency section)
- Pre-submission meeting with FDA
- Regulatory affairs review of model documentation
- Response tracking for regulatory questions

**Metrics:**
- Regulatory submission completeness score
- Number of regulatory questions on model transparency
- Time to respond to regulatory questions
- Approval status

---

## Implementation Guidelines

### Model Transparency Documentation Template

```yaml
model_transparency:
  model_architecture:
    type: "Convolutional Neural Network (CNN)"
    structure:
      input_shape: "[224, 224, 3]"
      layers: 
        - "Conv2D (32 filters, 3x3)"
        - "MaxPooling2D (2x2)"
        - "..."
        - "Dense (1, sigmoid)"
      parameters: 15000000
    input_features:
      - feature: "Medical Image"
        type: "RGB image"
        preprocessing: "Resize to 224x224, normalize to [0,1]"
    output:
      format: "Probability score [0,1]"
      interpretation: "Probability of disease presence"
  
  development_process:
    training_dataset: "Dataset-001 (N=10,000)"
    training_algorithm: "Adam optimizer, learning rate 0.001"
    validation_methodology: "5-fold cross-validation"
    model_selection: "Best AUC on validation set"
    performance_metrics:
      sensitivity: 0.92
      specificity: 0.88
      AUC: 0.94
  
  explainability:
    methods:
      - name: "SHAP"
        type: "local explanation"
        implementation: "shap.DeepExplainer"
      - name: "Grad-CAM"
        type: "visual explanation"
        implementation: "tf-keras-vis"
    explanation_validation:
      faithfulness: 0.85
      stability: 0.90
      clinical_review: "Approved by 3 radiologists"
  
  limitations:
    population: "Validated for adults age 18-80, not validated in pediatric population"
    input_data: "Requires high-quality images, JPEG compression >95%"
    performance: "Sensitivity 92% (95% CI: 0.89-0.95), may miss atypical presentations"
    failure_modes:
      - mode: "Low image quality"
        frequency: "5% of inputs"
        mitigation: "Image quality check, reject low-quality images"
  
  regulatory:
    submission_type: "510(k)"
    predicate_device: "Device X"
    fda_feedback_addressed: true
    approval_status: "Pending"
```

### Explainability Implementation Example

```python
# Example: SHAP explainability for model predictions
import shap

# Initialize explainer
explainer = shap.DeepExplainer(model, background_data)

# Generate explanation for a prediction
shap_values = explainer.shap_values(input_data)

# Visualize explanation
shap.image_plot(shap_values, input_data)

# Compute explanation metrics
faithfulness = compute_faithfulness(model, explainer, test_data)
stability = compute_stability(explainer, test_data, n_perturbations=100)

# Log explanation metrics
sc test log-evidence \
  --test-id "xai-validation" \
  --metric "faithfulness" \
  --value $faithfulness \
  --metric "stability" \
  --value $stability
```

---

## Integration Points

- **COMP-FDA-ML-002:** Model transparency supports clinical objective definition
- **COMP-EN18031-020:** Model explainability requirements
- **COMP-EN18031-006:** AI transparency requirements
- **COMP-IEC62304-003:** Software requirements include transparency requirements

---

## Audit Evidence

1. **Model Documentation:**
   - [ ] Model architecture documentation
   - [ ] Model development protocol
   - [ ] Version-controlled model documentation

2. **Explainability:**
   - [ ] Explainability method implementation
   - [ ] Explanation validation report
   - [ ] Clinical expert review of explanations
   - [ ] Usability testing results

3. **Limitations:**
   - [ ] Model limitations documentation
   - [ ] Failure mode and effects analysis (FMEA)
   - [ ] Risk management file
   - [ ] Labeling with limitations

4. **Regulatory:**
   - [ ] Regulatory submission (model transparency section)
   - [ ] Pre-submission meeting notes
   - [ ] Responses to regulatory questions

---

## References

- FDA (2021). "Good Machine Learning Practice for Medical Device Development: Guiding Principles"
- FDA (2019). "Clinical Decision Support Software: Guidance for Industry and FDA Staff"
- Rudin, C. (2019). "Stop Explaining Black Box Machine Learning Models for High Stakes Decisions"
- Lundberg & Lee (2017). "A Unified Approach to Interpreting Model Predictions" (SHAP)
- Ribeiro et al. (2016). "'Why Should I Trust You?': Explaining the Predictions of Any Classifier" (LIME)

---

## Revision History

| Version | Date       | Author            | Changes                                    |
|---------|------------|-------------------|--------------------------------------------|
| 1.0.0   | 2025-12-13 | Compliance Team   | Initial version - pending source verification |

---

## Notes

- **Status:** Pending verification with authoritative FDA sources
- **Priority:** HIGH - Critical for regulatory approval and clinical trust
- **Dependencies:** Requires completed model development and validation (COMP-FDA-ML-005)
- **Implementation Note:** Explainability requirements may vary based on device risk class and clinical use case



